IL24 and Alzheimer disease: To further validate the in vivo effect on AD-like inflammation induced by IL-24, we administrated recombinant human IL-24 (rhIL-24) protein to MC903-induced AD model through daily intradermal injection, with vehicle-injected group as control (Fig. 3G).